Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of Radspherin® ...
Early detection is not just about medical procedures or clinical appointments. It’s about empowerment, awareness and ...
In an interview with Targeted Oncology, Jeffrey Wong, MD, discussed the potential and future directions of Cu 64 anti-CEA M5A ...
Limerick breast cancer survivor calls on public to support Irish Cancer Society’s Big Pink Breakfast
BREAST cancer patient and Limerick native Catherine Kiely is supporting the Irish Cancer Society's Breast Cancer Awareness ...
With the Heat set to hold this year’s “Red, White & Pink Game” on Monday at 6 p.m. at Kaseya Center, proceeds from the scrimmage benefit cancer care and research at Baptist Health Miami Cancer ...
For 10 years, MemorialCare Breast Center physicians, care team members, mentors, cancer survivors, and employees have ...
Claire Jones is a six-year breast cancer survivor, but she still relies on the support of fellow survivors she met through ...
Two years later, she became the first paediatric patient to be offered a form of treatment called CAR-T, in which the body’s ...
MercyOneGenesis and the MercyOne Genesis Health Services Foundation are hosting the fourth annual Gather for the Cure on ...
Primary target patient population for the CBX-12 Phase 2 study is women with platinum-resistant or refractory ovarian cancer ...
Erika P. Hamilton, MD, discusses the patient population with breast cancer enrolled in the TROPION-PanTumor01 trial in ...
A cancer counsellor was diagnosed with an extremely rare cancer in December 2023 - vulvar mucosal melanoma - that she had 'never even heard of' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback